本页面由Tiger Trade Technology Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

15.68
0.0000
成交量:- -
成交额:5,379.51万
市值:3,741.19万
市盈率:-0.16
高:15.68
开:15.68
低:15.68
收:15.68
52周最高:15.68
52周最低:15.68
股本:238.60万
流通股本:238.44万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-96.2212
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):- -

数据加载中...

2021/09/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/16

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/19

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report